Imaging biomarkers serve as important end points for clinical trials in the approval process for therapeutic drugs. Various criteria have been developed for objective interpretation of imaging studies.
Imaging Biomarkers in Clinical Trials
Apr 24th, 2014Apr 25th, 2014
Latest in Home
DEXA study questions OsteoStrong claims
September 22, 2025
MWA successful in treating multinodal thyroid conditions
September 22, 2025
AI industry paid $39.7M for radiology devices between 2017 and 2023
September 22, 2025
Radiation oncologists put RefleXion’s X1 system to the test
September 19, 2025